EP. 2: CBD, THC’s Mild-Mannered Kin, is a Risk Worth Watching

(+2 rating, 2 votes)

Loading...

6,407 views

---

---

Cannabidiol (CBD), a chemical compound from the Cannabid sativa plant, may be less potent than its stony cannabis cousin THC, however CBD might be the far riskier relative. Nearly a dozen major CBD-related class action lawsuits, as well as a handful of legal and regulatory actions against some CBD companies, are pending. All of this bears watching by those in the sector who manage and deal in risk.

Other videos you might like:

• EP.43: Who are the Insuring Cannabis Brokers?
• EP. 31: More Than a Conversation: Cyber, Insurance Pros Say Building Diversity Means Taking Action
• EP.38: There’s Opportunity, but Also Risk in Rare and Minor Cannabinoids
• EP. 36: California Law Opens up Foods and Cosmetics for CBD, but it Could Create Heavy Regs